4.8 Article

Angiopoietin-1 is required for Schlemm's canal development in mice and humans

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 127, 期 12, 页码 4421-4436

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI95545

关键词

-

资金

  1. NIH [R01 HL124120, R01 EY025799, R01 EY014685]
  2. Research to Prevent Blindness Inc.
  3. University of Wisconsin
  4. March of Dimes Foundation
  5. NEI [P30EY014104]
  6. Howard Hughes Medical Center
  7. Ophthalmic Research Institute of Australia
  8. Channel Seven Children's Research Foundation
  9. Department of Innovation, Industry, Science and Research (Australia)
  10. National Health and Medical Research Council of Australia
  11. Japan Society for the Promotion of Science
  12. Mallinckrodt Pharmaceuticals
  13. NCI CCSG [P30 CA060553]
  14. Northwestern University Transgenic and Targeted Mutagenesis Laboratory
  15. Cancer Center Support Grant [NCI CA060553]
  16. Vision Core Grant [NEI P30EY016665]
  17. University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences
  18. EY [11721]

向作者/读者索取更多资源

Primary congenital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by developmental defects in 2 aqueous humor outflow structures, Schlemm's canal (SC) and the trabecular meshwork. We previously identified loss-of-function mutations in the angiopoietin (ANGPT) receptor TEK in families with PCG and showed that ANGPT/TEK signaling is essential for SC development. Here, we describe roles for the major ANGPT ligands in the development of the aqueous outflow pathway. We determined that ANGPT1 is essential for SC development, and that Angpt1-knockout mice form a severely hypomorphic canal with elevated intraocular pressure. By contrast, ANGPT2 was dispensable, although mice deficient in both Angpt1 and Angpt2 completely lacked SC, indicating that ANGPT2 compensates for the loss of ANGPT1. In addition, we identified 3 human subjects with rare ANGPT1 variants within an international cohort of 284 PCG patients. Loss of function in 2 of the 3 patient alleles was observed by functional analysis of ANGPT1 variants in a combined in silico, in vitro, and in vivo approach, supporting a causative role for ANGPT1 in disease. By linking ANGPT1 with PCG, these results highlight the importance of ANGPT/TEK signaling in glaucoma pathogenesis and identify a candidate target for therapeutic development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据